Generics Industry Urges Fed. Circ. To Fix Arthrex 'Disarray'

By Dani Kass ( January 3, 2020, 7:42 PM EST) -- The generic-drug industry and a group of New York intellectual property lawyers have urged the full Federal Circuit to reconsider a panel's decision that Patent Trial and Appeal Board judges have been unconstitutionally appointed, with one group warning of disarray, and the other of "devastating consequences."...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!